Isoalantolactone Enhances the Antitumor Activity of Doxorubicin by Inducing Reactive Oxygen Species and DNA Damage

Colon cancer is one of the most common cancer in the world. Doxorubicin (DOX) is a classical anti-tumor drug which widely used in treatment of cancers, however, high toxicity limited its further clinical application. Thus, it is urgent to find new drugs with low toxicity and high efficiency to treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Fengjiao, Shao, Rongrong, Zheng, Peisen, Zhang, Tingting, Qiu, Chenyu, Sui, Hehuan, Li, Shaotang, Jin, Libo, Pan, Huanle, Jin, Xiance, Zou, Peng, Cui, Ri, Xie, Congying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821528/
https://www.ncbi.nlm.nih.gov/pubmed/35145916
http://dx.doi.org/10.3389/fonc.2022.813854

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821528/
https://www.ncbi.nlm.nih.gov/pubmed/35145916
http://dx.doi.org/10.3389/fonc.2022.813854

Ejemplares similares